Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

24 août 2017 01h00 HE | Source: argenx SE

argenx reports second quarter business update and half-year 2017 financial results

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Management to host conference call today...
23 août 2017 01h00 HE | Source: argenx SE

argenx announces publication in Nature Medicine of preclinical data supporting the therapeutic potential of SIMPLE AntibodyTM ARGX-116 for the treatment of dyslipidemia

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} -anti-ApoC3 antibody developed as part...
17 août 2017 01h00 HE | Source: argenx SE

argenx to host conference call & webcast to report second quarter business update and half year 2017 financial results on August 24, 2017

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Breda, the Netherlands / Ghent, Belgium...
08 août 2017 01h00 HE | Source: argenx SE

argenx to Present at Wedbush PacGrow Healthcare Conference

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Breda, the Netherlands / Ghent, Belgium...
07 juil. 2017 01h00 HE | Source: argenx SE

argenx presents full data from ARGX-111 Phase Ib study in patients with advanced cancers over-expressing the MET protein at Best of ASCO Asia 2017 (Singapore)

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} July 7, 2017 Breda, the Netherlands /...
20 juin 2017 01h00 HE | Source: argenx SE

argenx receives second preclinical milestone payment in collaboration with LEO Pharma

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} June 20, 2017Breda, the Netherlands /...
14 juin 2017 02h00 HE | Source: argenx SE

argenx presents update on Phase I data from ARGX-110 expansion study in patients with cutaneous T-cell lymphomas at the International Conference of Malignant Lymphoma (ICML)

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} June 14, 2017 Breda, the Netherlands /...
13 juin 2017 01h00 HE | Source: argenx SE

argenx to Present at JMP Securities Life Sciences Conference

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} June 13, 2017 Breda, the Netherlands /...
23 mai 2017 16h00 HE | Source: argenx SE

argenx announces closing of NASDAQ IPO

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Regulated information Breda, the...
19 mai 2017 09h00 HE | Source: argenx SE

argenx announces full exercise of underwriters' option to purchase additional ADSs

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Regulated information - inside...

Page précédente